Scarica l'app Stockscreener
5.94
3.73%
-0.23
Dopo l'orario di chiusura:
5.97
0.03
+0.51%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RXRX Giù?
Forum
Previsione
Recursion Pharmaceuticals Inc Borsa (RXRX) Ultime notizie
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - AOL
Proficio Capital Partners LLC Makes New $163,000 Investment in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) - Defense World
Recursion Pharmaceuticals: Stretched Thin And Chasing Unicorns - Seeking Alpha
Jim Cramer on Recursion Pharmaceuticals, Inc. (RXRX): ‘We’re Going To Have To Hold Off’ - Insider Monkey
Recursion Pharma Gets A Price-Target Cut After Q4 Miss: Retail Bearish Even As Cathie Wood's Ark Buys The Dip - MSN
Why Recursion Pharmaceuticals Stock Is Sinking Today - Yahoo Finance
Jim Cramer’s Latest Lightning Round: 8 Stocks in Focus - Insider Monkey
Is This Beaten-Down Artificial Intelligence (AI) Stock a Buy? - Nasdaq
Cathie Wood-Led Ark Invest Roblox, Roku, UiPath As Markets Take A Dip - Benzinga
QRG Capital Management Inc. Grows Holdings in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) - Defense World
This Is What Whales Are Betting On Recursion Pharmaceuticals - Benzinga
Private Advisor Group LLC Increases Stake in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) - Defense World
4 Things You Need to Know if You Buy Recursion Pharmaceuticals Stock Today - MSN
This Biotech Stock Could Be the Best Investment of the Decade - The Globe and Mail
April 25th Options Now Available For Recursion Pharmaceuticals (RXRX) - Nasdaq
Down Over 40%, Is Recursion Pharmaceuticals a Buy on the Dip? - MSN
IFP Advisors Inc Acquires 7,455 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) - Defense World
Recursion Pharmaceuticals (RXRX) Remains Optimistic Despite Q4 Disappointment - TipRanks
TechBio Latest News - substack.com
How To Trade (RXRX) - Stock Traders Daily
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q4 2024 Earnings Call Transcript - MSN
News Flash: Analysts Just Made A Sizeable Upgrade To Their Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Forecasts - Yahoo Finance
Recursion Pharmaceuticals Shares Dip Amid Revenue Timing - TipRanks
Why Recursion Pharmaceuticals, Inc. (RXRX) Crashed on Monday - MSN
Rhumbline Advisers Has $2.26 Million Stock Holdings in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) - Defense World
Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Down 5.3% on Disappointing Earnings - Defense World
Recursion Pharmaceuticals Inc (RXRX) Q4 2024 Earnings Call Highlights: Strong Financial ... By GuruFocus - Investing.com Canada
Recursion Pharmaceuticals projects $100M synergies in 2025 amid advancing pipeline and partnerships - MSN
Recursion Pharmaceuticals’ Earnings Call Highlights Growth - TipRanks
Recursion Pharmaceuticals (NasdaqGS:RXRX) Surges 6% Following US$500 Million Follow-On Equity Offering - Yahoo Finance
Recursion Pharmaceuticals' Update Could Shed Light On Pipeline, Cost-Saving Plans, Analyst Says - Benzinga India
Atria Wealth Solutions Inc. Invests $75,000 in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) - Defense World
This Just In: Analysts Are Boosting Their Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Outlook for This Year - Simply Wall St
Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Gap Down After Earnings Miss - Defense World
Recursion Pharmaceuticals Stock Scores RS Ratings Over 90 - MSN
AI Drug Firm Recursion Wants to Be the Amazon Prime of Pharma - Advisor Perspectives
Cathie Wood's Ark Invest Loads Up On Tempus AI, Archer Aviation, But Sells Twist Bioscience: Here Are Key Ark Trades This FridayArcher Aviation (NYSE:ACHR), Accolade (NASDAQ:ACCD) - Benzinga
Recursion stock holds as Cowen sees merger synergies By Investing.com - Investing.com Canada
Recursion Pharmaceuticals Reports Mixed 2024 Financial Results - TipRanks
Cathie Wood’s ARK ETF bolsters Tempus AI, Recursion stocks By Investing.com - Investing.com Australia
Cathie Wood's ARK ETF bolsters Tempus AI, Recursion stocks - Investing.com
Cathie Wood’s ARK ETF bolsters Tempus AI, Recursion stocks - Investing.com India
Strong Buy Recommendation for Recursion Pharmaceuticals: Leading Techbio Innovator with Robust Financials and Strategic AI Integration - TipRanks
Best Biotech Stocks To Keep An Eye OnFebruary 28th - MarketBeat
Recursion Pharmaceuticals (RXRX) Reports Q4 Loss, Lags Revenue Estimates - MSN
Recursion Pharmaceuticals misses Q4 estimates, shares dip By Investing.com - Investing.com Australia
Recursion Pharmaceuticals misses Q4 estimates, shares dip - Investing.com
0.49%
1.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):